SFM
EBS icon

Signet Financial Management’s Emergent Biosolutions EBS Stock Holding History

Signet Financial Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-59
Closed -$3K – 535
2021
Q4 		$3K Buy
+59
New +$2.67K ﹤0.01% 1250
2018
Q4 		– Sell
-132
Closed -$9K – 392
2018
Q3 		$9K Buy
132
+102
+340% +$5.95K ﹤0.01% 642
2018
Q2 		$2K Sell
30
-27
-47% -$1.41K ﹤0.01% 811
2018
Q1 		$3K Buy
+57
New +$2.84K ﹤0.01% 715

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Signet Financial Management's EBS Position: Q1 2022 in Review

Signet Financial Management sold out of Emergent Biosolutions (EBS) in Q1 2022, closing a stake of 59 shares — an estimated $3K sold.

Signet Financial Management first reported a position in EBS in Q1 2018 and held it in 4 quarters. The position peaked at $9K in Q3 2018. 255 funds tracked by Wall St. Rank hold EBS as of Q1 2022.

  • Signet Financial Management reported no remaining Emergent Biosolutions position as of Q1 2022 after selling out during the quarter.
  • Signet Financial Management sold 59 Emergent Biosolutions shares in Q1 2022, an estimated $3K.
  • Signet Financial Management first reported a position in Emergent Biosolutions in Q1 2018 and held it in 4 quarters.
  • Signet Financial Management's Emergent Biosolutions position peaked at $9K in Q3 2018.
  • 255 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.